Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EP-TRACER System

K-Number: K183266 · 2019-03-01

Decision Date2019-03-01
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

EP-TRACER System is a medical device manufactured by Schwarzer Cardiotek GmbH. It received FDA 510(k) clearance on 2019-03-01 under approval number K183266. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EP-TRACER System?

EP-TRACER System is a medical device that received FDA 510(k) clearance on 2019-03-01. It is manufactured by Schwarzer Cardiotek GmbH. The 510(k) number is K183266.

When was EP-TRACER System approved by the FDA?

EP-TRACER System received FDA 510(k) clearance on 2019-03-01, under approval number K183266.

What company makes EP-TRACER System?

EP-TRACER System is manufactured by Schwarzer Cardiotek GmbH.

What is the FDA product code for EP-TRACER System?

The FDA product code for EP-TRACER System is DQK.

Related Clinical Trials

Related Devices (Code: DQK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.